Pembrolizumab biosimilar
Product Description
Chengdu Brilliant Pharmaceutical Group.Inc
-
Country/Region:China
-
On CPHI since:2026
Categories
Chengdu Brilliant Pharmaceutical Group.Inc
-
Country/Region:China
-
On CPHI since:2026
More Products from Chengdu Brilliant Pharmaceutical Group.Inc (4)
-
Product Azithromycin for Injection
Azithromycin for Injection is a macrolide antibiotic used for susceptible bacterial infections of the respiratory tract, skin and soft tissue, and urogenital tract. It is given intravenously when oral therapy is not feasible or for more severe cases, often followed by oral step-down. It offers high tissue ... -
Product Budesonide Inhalation Suspension
Budesonide Inhalation Suspension provides potent local anti-inflammatory action in the airways, reduces airway hyperresponsiveness, and is delivered directly to the lungs via nebulization for fast onset with relatively low systemic exposure—helping improve asthma symptom control and reduce the risk of acut... -
Product Gadoxetate Disodium Injection
Gadoxetate Disodium Injection is a liver-specific MRI contrast agent for enhanced imaging: dynamic phase shows perfusion, hepatobiliary phase highlights lesion–liver contrast. It improves detection and characterization of small HCC and metastases, offers better lesion contrast, no ionizing radiation, and a... -
Product Semaglutide
Semaglutide is a GLP-1 receptor agonist that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon, delays gastric emptying, and reduces appetite. It is mainly used for glycemic control in type 2 diabetes; some doses are approved for weight management in obesity/overweight, with e...



